Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

Faculty Disclosures

Merry Sebelik, MD - Nothing to Disclose
Marc Coltera, MD - Nothing to Disclose
Arjun Joshi, MD - Nothing to Disclose
David Shonka, MD - Nothing to Disclose
Alice Tang, MD - Nothing to Disclose
Marika Russell, MD - Nothing to Disclose
Chris Fundakowski, MD - Nothing to Disclose
Elizabeth Cottrill, MD - Nothing to Disclose
Julia, Noel, MD - Consultant, Pulse Biosciences
Nitin Pagedar, MD - Nothing to Disclose
William Brundage, MD - Nothing to Disclose
Erin Buczek, MD - Nothing to Disclose
Vinay Fernandes, MD - Nothing to Disclose
William Armstrong, MD - Nothing to Disclose
Brandon Prendes, MD - Nothing to Disclose

Planning Committee Disclosure

Ellen J. Hagopian, MD, MHPE, FACS, FSSO – Nothing to Disclose
Paula Ferrada, MD, FACS, FCCM, MAMSE – Nothing to Disclose
Stefan Scholz, MD, PhD, FACS, FAAP – Nothing to Disclose
Russell B. Smith, MD, FACS – Nothing to Disclose
Anthony Anagnostou, MD, FACS – Nothing to Disclose
Richard E. Fine, MD, FACS   – Nothing to Disclose
Lawrence T. Kim, MD, FACS, FACE – Nothing to Disclose
Laura S. Johnson, MD, FACS – Nothing to Disclose
Barbra Miller, MD, FACS – Nothing to Disclose
Lisa A. Orloff, M.D., FACS, FACE – Nothing to Disclose
R. Eugene Zierler, MD RPVI, FACS – Nothing to Disclose
Nicholas J. Zyromski, MD, FACS – Nothing to Disclose